Curis Inc. is set to hold a special meeting for its stockholders on November 18, 2026, to vote on a proposed reverse stock split. This decision is significant as it aims to boost the company's stock price and enhance its market appeal. The reverse stock split could potentially attract more investors and improve the company's standing within the biological products industry.
About Curis Inc.
Curis Inc. is a biotechnology company incorporated in Delaware, primarily involved in the development of biological products, excluding diagnostic substances. The company trades on the Nasdaq under the ticker symbol CRIS. According to its recent filings, Curis is categorized as a smaller reporting company and is classified under the SIC code 2836, which pertains to biological products.
What the Filing Says
The definitive proxy statement filed on November 2, 2026, outlines the agenda for the upcoming special meeting. It states, "To adopt and approve amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our shares of common stock, by a ratio ranging from any whole number between 1-for-5 and 1-for-12, as determined by our Board of Directors." This proposal is intended to allow the board flexibility in deciding the exact ratio for the reverse stock split.
Impact
The proposed reverse stock split may affect current stockholders by consolidating shares, which could lead to a higher stock price per share. This move is often seen as a strategy to improve the perception of a company's stock, especially if the share price has fallen below a certain level. The decision could also influence potential investors' interest in the company.
What's Next
The special meeting will take place virtually, allowing stockholders to participate online. The filing indicates that stockholders are encouraged to vote either by submitting proxies over the Internet, by telephone, or by mail. The board has set October 26, 2026, as the record date for determining stockholders eligible to vote at the meeting. This allows ample time for stockholders to prepare and ensure their voices are heard regarding the proposed reverse stock split.
Read Next
Raab & Moskowitz Asset Management reports $503M in holdings
College Retirement Equities Fund suspends Income Test Drive feature
MFS Series Trust XVII Certifies No Changes in Fund Documents
Eddie Patel Inc reports Q3 2026 holdings in 13F filing
Alecta Tjanstepension Omsesidigt Releases Latest 13F Holdings
Electrovaya ranks fourth in Deloitte's Technology Fast 50








